POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 65 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,675 | -93.0% | 1,124 | -94.8% | 0.00% | – |
| Q2 2023 | $38,210 | -90.1% | 21,710 | -82.6% | 0.00% | – |
| Q1 2023 | $385,120 | -55.6% | 125,039 | -23.6% | 0.00% | -100.0% |
| Q4 2022 | $867,478 | +8574.8% | 163,675 | +5651.1% | 0.00% | – |
| Q3 2022 | $10,000 | +150.0% | 2,846 | +103.0% | 0.00% | – |
| Q2 2022 | $4,000 | -76.5% | 1,402 | -62.7% | 0.00% | – |
| Q1 2022 | $17,000 | -72.6% | 3,757 | -58.5% | 0.00% | – |
| Q4 2021 | $62,000 | +29.2% | 9,060 | +36.3% | 0.00% | – |
| Q3 2021 | $48,000 | -18.6% | 6,645 | +11.9% | 0.00% | – |
| Q2 2021 | $59,000 | +84.4% | 5,937 | +76.0% | 0.00% | – |
| Q1 2021 | $32,000 | -33.3% | 3,373 | -23.4% | 0.00% | – |
| Q4 2020 | $48,000 | +700.0% | 4,405 | +582.9% | 0.00% | – |
| Q3 2020 | $6,000 | – | 645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |